Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 65, Number 3, August 09, 2005
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rascovsky, K.
Right arrow Articles by Galasko, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rascovsky, K.
Right arrow Articles by Galasko, D.
Related Collections
Right arrow MRI
Right arrow Volumetric MRI
Right arrow All Neuropsychology/Behavior
Right arrow Alzheimer's disease
Right arrow Frontotemporal dementia
NEUROLOGY 2005;65:397-403
© 2005 American Academy of Neurology

Rate of progression differs in frontotemporal dementia and Alzheimer disease

K. Rascovsky, MA, D. P. Salmon, PhD, A. M. Lipton, MD, PhD, J. B. Leverenz, MD, C. DeCarli, MD, W. J. Jagust, MD, C. M. Clark, MD, M. F. Mendez, MD, PhD, D. F. Tang-Wai, MD, N. R. Graff-Radford, MD and D. Galasko, MD

From the University of California, San Diego (Drs. Rascovsky, Salmon, and Galasko); The University of Texas Southwestern Medical Center (Dr. Lipton), Dallas; University of Washington (Dr. Leverenz), Seattle; University of California, Davis (Dr. DeCarli); University of California, Berkeley (Dr. Jagust); University of Pennsylvania (Dr. Clark), Philadelphia; University of California, Los Angeles (Dr. Mendez); Mayo Clinic (Drs. Tang-Wai and Graff-Radford), Jacksonville, FL.

Address correspondence and reprint requests to Dr. David Salmon, Alzheimer's Disease Research Center, University of California, San Diego, Mail Code 0948, 9500 Gilman Drive, La Jolla, CA 92093-0948; e-mail: dsalmon{at}ucsd.edu

Objective: To compare survival and rates of cognitive and functional decline in patients with autopsy-confirmed frontotemporal dementia (FTD) and Alzheimer disease (AD) in a large multicenter study.

Background: Despite advances in the clinical characterization of FTD, little is known about its rate of progression. Characterizing survival and rate of decline in FTD is important because it can provide prognostic guidelines and benchmarks to use in the evaluation of disease-modifying drugs.

Methods: Seventy patients with FTD and 70 patients with AD who were followed by seven Alzheimer disease research centers until confirmation of diagnosis at autopsy were matched for overall age, education, and Mini-Mental State Examination (MMSE) score at initial evaluation. Survival and rates of cognitive and functional decline were compared.

Results: Patients with FTD had significantly shorter survival from initial evaluation to death than patients with AD (FTD = 4.2 years, AD = 6.0 years; log-rank test = 5.17, p < 0.05), and they declined significantly faster over one year on the MMSE (mean annual rate of change: –6.7 points for FTD vs –2.3 points for AD). A significantly greater proportion of patients with FTD were impaired in basic activities of daily living (ADLs) at initial evaluation, and lost the capacity for independent or minimally-assisted ADLs over the subsequent year.

Conclusions: The results are consistent with shorter survival and faster rates of cognitive and functional decline in patients with frontotemporal dementia (FTD) compared to those with Alzheimer disease (AD). This suggests that FTD follows a more malignant disease course than AD once dementia is clinically recognized.


This study was supported with funding from the National Alzheimer's Coordinating Center and NIA grants P30 AG10129, P30 AG-12300, P50 AG16574, P50 AG10124, P50 AG05131 and P50 AG05136.

Disclosure: The authors report no conflicts of interest.

Received November 3, 2004. Accepted in final form April 18, 2005.




This article has been cited by other articles:


Home page
Arch NeurolHome page
S. J. Kile, W. G. Ellis, J. M. Olichney, S. Farias, and C. DeCarli
Alzheimer Abnormalities of the Amygdala With Kluver-Bucy Syndrome Symptoms: An Amygdaloid Variant of Alzheimer Disease
Arch Neurol, January 1, 2009; 66(1): 125 - 129.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. S. Knopman, J. H. Kramer, B. F. Boeve, R. J. Caselli, N. R. Graff-Radford, M. F. Mendez, B. L. Miller, and N. Mercaldo
Development of methodology for conducting clinical trials in frontotemporal lobar degeneration
Brain, November 1, 2008; 131(11): 2957 - 2968.
[Abstract] [Full Text] [PDF]


Home page
Age AgeingHome page
M. Meguro, M. Kasai, K. Akanuma, H. Ishii, S. Yamaguchi, and K. Meguro
Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project
Age Ageing, July 1, 2008; 37(4): 469 - 473.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S X Xie, M S Forman, J Farmer, P Moore, Y Wang, X Wang, C M Clark, H B Coslett, A Chatterjee, S E Arnold, et al.
Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration
J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 126 - 129.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
W. W. Seeley, R. Crawford, K. Rascovsky, J. H. Kramer, M. Weiner, B. L. Miller, and M. L. Gorno-Tempini
Frontal Paralimbic Network Atrophy in Very Mild Behavioral Variant Frontotemporal Dementia
Arch Neurol, February 1, 2008; 65(2): 249 - 255.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
J. E. Osher, A. H. Wicklund, A. Rademaker, N. Johnson, and S. Weintraub
The Mini-Mental State Examination in Behavioral Variant Frontotemporal Dementia and Primary Progressive Aphasia
American Journal of Alzheimer's Disease and Other Dementias, January 1, 2008; 22(6): 468 - 473.
[Abstract] [PDF]


Home page
BrainHome page
S. Alladi, J. Xuereb, T. Bak, P. Nestor, J. Knibb, K. Patterson, and J. R. Hodges
Focal cortical presentations of Alzheimer's disease
Brain, October 1, 2007; 130(10): 2636 - 2645.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Grossman, E. M. Wood, P. Moore, M. Neumann, L. Kwong, M. S. Forman, C. M. Clark, L. F. McCluskey, B. L. Miller, V. M.-Y. Lee, et al.
TDP-43 Pathologic Lesions and Clinical Phenotype in Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions
Arch Neurol, October 1, 2007; 64(10): 1449 - 1454.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. D. Rabinovici, A. J. Furst, J. P. O'Neil, C. A. Racine, E. C. Mormino, S. L. Baker, S. Chetty, P. Patel, T. A. Pagliaro, W. E. Klunk, et al.
11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
Neurology, April 10, 2007; 68(15): 1205 - 1212.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
I. L. Ber, E. Guedj, A. Gabelle, P. Verpillat, M. Volteau, C. Thomas-Anterion, M. Decousus, D. Hannequin, P. Vera, L. Lacomblez, et al.
Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia.
Brain, November 1, 2006; 129(Pt 11): 3051 - 3065.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Kertesz, D. P. Salmon, D. Galasko, and K. Rascovsky
Rate of progression differs in frontotemporal dementia and Alzheimer disease
Neurology, May 23, 2006; 66(10): 1607 - 1607.
[Full Text] [PDF]


Home page
BrainHome page
C. Vance, A. Al-Chalabi, D. Ruddy, B. N. Smith, X. Hu, J. Sreedharan, T. Siddique, H. J. Schelhaas, B. Kusters, D. Troost, et al.
Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3
Brain, April 1, 2006; 129(4): 868 - 876.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. J. Strong
ALS--Not What We Thought.
Arch Neurol, March 1, 2006; 63(3): 319 - 320.
[Full Text] [PDF]


Home page
JWatch PsychiatryHome page
Rates of Decline and Survival in FTLD and Its Subtypes
Journal Watch Psychiatry, December 21, 2005; 2005(1221): 9 - 9.
[Full Text]


Home page
JWatch NeurologyHome page
Survival in FTD Decreased Compared to AD
Journal Watch Neurology, December 8, 2005; 2005(1208): 2 - 2.
[Full Text]


Home page
JWatch NeurologyHome page
Rates of Decline and Survival in FTLD and Its Subtypes
Journal Watch Neurology, November 3, 2005; 2005(1103): 1 - 1.
[Full Text]

Correspondence:

Read all Correspondence

Rate of progression differs in frontotemporal dementia and Alzheimer disease
Andrew Kertesz, MD, FRCP(C), FAAN
Neurology Online, 28 Mar 2006 [Full text]
Reply from the authors
David P. Salmon, PhD, et al.
Neurology Online, 28 Mar 2006 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.